Similar results were observed in the HT-29 CRC cells: the Bax/Bcl-2 ratio was significantly increased by 2.31- and 4.1-fold at 24 and 48 h, respectively, compared to the control. This evidence concerns the gene BCL2 and colorectal carcinoma.